These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 32737696)

  • 41. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
    Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
    Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of the axilla post-neoadjuvant chemotherapy in node positive breast cancer: Can the combination of axillary ultrasound and tumor biomarkers improve patient selection for sentinel node biopsy?
    Dinneen K; O'Brien C; Quinn CM; Sweeney EL; Byrnes KG; McNally SM; Prichard RS; Gibbons D
    Breast J; 2021 Apr; 27(4):394-396. PubMed ID: 33527552
    [No Abstract]   [Full Text] [Related]  

  • 44. Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).
    Boughey JC; Ballman KV; Le-Petross HT; McCall LM; Mittendorf EA; Ahrendt GM; Wilke LG; Taback B; Feliberti EC; Hunt KK
    Ann Surg; 2016 Apr; 263(4):802-7. PubMed ID: 26649589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
    Pecha V; Kolarik D; Kozevnikova R; Hovorkova K; Hrabetova P; Halaska M; Sottner O; Trnkova M; Petruzelka L; Kolarova H
    Cancer; 2011 Oct; 117(20):4606-16. PubMed ID: 21437896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is sentinel lymph node biopsy a viable alternative to complete axillary dissection following neoadjuvant chemotherapy in women with node-positive breast cancer at diagnosis? An updated meta-analysis involving 3,398 patients.
    El Hage Chehade H; Headon H; El Tokhy O; Heeney J; Kasem A; Mokbel K
    Am J Surg; 2016 Nov; 212(5):969-981. PubMed ID: 27671032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ASO Author Reflections: Male Breast Cancer and Axillary Lymph Node Dissection: Time to Rethink the Algorithm?
    Chung SH; Cassidy MR
    Ann Surg Oncol; 2023 Sep; 30(9):5619-5620. PubMed ID: 37191857
    [No Abstract]   [Full Text] [Related]  

  • 48. Staging of the Axilla After Neoadjuvant Chemotherapy: Which Technique is Better? The Endless Debate.
    Montagna G; El-Tamer MB
    Ann Surg Oncol; 2023 Oct; 30(11):6290-6292. PubMed ID: 37394672
    [No Abstract]   [Full Text] [Related]  

  • 49. The sentinel lymph node as a viable alternative to axillary lymph node dissection after neoadjuvant breast cancer chemotherapy. A diagnostic accuracy analysis.
    Merayo Álvarez M; Alonso Martínez B; Calvo Rodríguez D; Ortiz Del Olmo D; Llaneza Folgueras MA
    Cir Esp (Engl Ed); 2023 Jul; 101(7):510-512. PubMed ID: 35724877
    [No Abstract]   [Full Text] [Related]  

  • 50. Refining the Performance of Sentinel Lymph Node Biopsy Post-neoadjuvant Chemotherapy in Patients with Pathologically Proven Pre-treatment Node-positive Breast Cancer: An Update for Clinical Practice.
    El Hage Chehade H; Headon H; Kasem A; Mokbel K
    Anticancer Res; 2016 Apr; 36(4):1461-71. PubMed ID: 27069121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does Lymph Node Status Prior to Neoadjuvant Chemotherapy Influence the Number of Sentinel Nodes Removed?
    Baker JL; Muhsen S; Zabor EC; Stempel M; Gemignani ML
    Ann Surg Oncol; 2019 Feb; 26(2):336-342. PubMed ID: 30506175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Assessment of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy in breast cancer: before or after?].
    Coutant C; Jankowski C; Portha H; Barranger E
    Gynecol Obstet Fertil; 2016 Jun; 44(6):345-9. PubMed ID: 27234216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer.
    Gatek J; Vrana D; Hnatek L; Bakala J; Dudesek B; Duben J; Musil T
    J BUON; 2012; 17(2):265-70. PubMed ID: 22740204
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sentinel node biopsy in post-neoadjuvant chemotherapy breast cancer patients using preoperative breast tattooing-A novel technique.
    Bhargavan RV; Augustine P; Krishna JKM; Radhakrishnan N
    Breast J; 2021 Mar; 27(3):284-286. PubMed ID: 33506981
    [No Abstract]   [Full Text] [Related]  

  • 55. ASO Author Reflections: A Negative Axillary Clinical Exam Adequately Identifies Clinically Node-Positive Patients who Downstage After NAC and are Candidates for SLNB.
    Moo TA; Morrow M
    Ann Surg Oncol; 2019 Dec; 26(13):4244-4245. PubMed ID: 31617121
    [No Abstract]   [Full Text] [Related]  

  • 56. ASO Author Reflections: Analyzing the Trends for Axillary Lymph Node Surgery in Patients with Ductal Carcinoma In Situ: A Comparison Against National Guidelines.
    Pyfer BJ; Chatterjee A
    Ann Surg Oncol; 2020 Sep; 27(9):3456-3457. PubMed ID: 32232707
    [No Abstract]   [Full Text] [Related]  

  • 57. ASO Author Reflections: Sequence of Treatment in Clinically Node-Negative T1 Triple-Negative Breast Cancer.
    Huang K; Jakub JW; McLaughlin SA
    Ann Surg Oncol; 2023 Dec; 30(13):8455-8456. PubMed ID: 37566286
    [No Abstract]   [Full Text] [Related]  

  • 58. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
    Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
    Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node.
    Patel R; MacKerricher W; Tsai J; Choy N; Lipson J; Ikeda D; Pal S; De Martini W; Allison KH; Wapnir IL
    Ann Surg Oncol; 2019 Aug; 26(8):2452-2458. PubMed ID: 31087176
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
    Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.